Jaclyn Blaisdell
About Jaclyn Blaisdell
Jaclyn Blaisdell is the Director of Cell Therapy Quality Assurance at Bristol Myers Squibb, with over a decade of experience in quality assurance and validation within the biotechnology and pharmaceutical industries.
Current Position at Bristol Myers Squibb
Jaclyn Blaisdell is currently serving as the Director of Cell Therapy Quality Assurance at Bristol Myers Squibb. In this role, she oversees quality assurance strategies and standards specifically for cell therapy. She transitioned to this position in July 2022, bringing with her extensive experience in both quality engineering and validation. Her responsibilities include ensuring that cell therapy products meet stringent quality and regulatory requirements.
Previous Roles at Bristol Myers Squibb
Prior to her current role, Jaclyn worked as an Associate Director of Quality Engineering Cell Therapy at Bristol Myers Squibb. She held this position from 2020 to 2022, based in Devens, MA. During this period, she contributed to quality engineering initiatives specifically focused on cell therapy, leveraging her extensive background in quality assurance and validation.
Experience at Sanofi
Jaclyn Blaisdell held several important roles at Sanofi from 2012 to 2020. Her final role was as Associate Director - Commissioning, Qualification, and Validation from 2018 to 2020. She also served as a Manager in various capacities including Engineering Validation and Operational Readiness. Earlier, she was a Validation Engineer III / Validation Supervisor and a Senior Quality Engineer working on Consent Decree Quality System Remediation.
Background in Validation Engineering
With over a decade of experience, Jaclyn has a comprehensive background in validation engineering. She started her career at Biometrix Corporation, then moved to Pfizer (formerly Wyeth Biotech) and served as a validation engineer. She further enhanced her experience as an independent Validation Consultant from 2010 to 2012. At these positions, she specialized in ensuring compliance with regulatory standards and improving validation processes across the biotechnology and pharmaceutical sectors.
Educational Background
Jaclyn Blaisdell holds a Bachelor of Science in Mechanical Engineering from Worcester Polytechnic Institute. She further advanced her education by earning a Master of Science in Manufacturing Engineering from Boston University. Her strong academic background has been foundational to her successful career in quality assurance and validation within the biotech and pharmaceutical industries.